Tarsus Pharmaceuticals Inc (TARS)
SG&A Expense Growth
10.46%
Quarterly · Period ending:
TARS SG&A Expense Growth
Latest reported10.46%period ending
Latest reported10.46%period ending
TARS Quarterly SG&A Growth (QoQ) (0.00% → 10.46%)
Latest values, visible window
High-resolution chart · PNG
TARS sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 10.4582% | |
| 4.3977% | |
| 20.2968% | |
| 5.4556% | |
| 21.1989% | |
| 23.1276% | |
| 19.2022% | |
| -1.5002% | |
| 13.9866% | |
| 19.9349% | |
| 41.8184% | |
| 51.9315% | |
| 34.4855% | |
| 1.4214% | |
| 24.1874% | |
| 13.5601% | |
| 30.5814% | |
| 17.3361% | |
| 1.514% | |
| -1.8104% | |
| 31.6667% | |
| 32.6478% | |
| 80.9302% | |
| 40.8912% | |
| 151.8152% | |
| 56.5891% | |
| 80.8411% | |
| 0% | |
| 0% | |
| 0% |